Similar articles

• Serum dopamine beta-hydroxylase.

  Weinshilboum RM. Weinshilboum RM. Pharmacol Rev. 1978 Jun;30(2):133-66. Pharmacol Rev. 1978. PMID: 382186 Review. No abstract available.
• [Study on Dopamine-beta-hydroxylase activity in serum in patients with essential hypertension at rest and during exercise (author's transl)].

  Doijiri K. Doijiri K. Nihon Naibunpi Gakkai Zasshi. 1979 May 20;55(5):710-9. doi: 10.1507/endocrine1927.55.5_710. Nihon Naibunpi Gakkai Zasshi. 1979. PMID: 467741 Japanese. No abstract available.
• [Dopamine-beta-hydroxylase activity, aldosterone level, and plasma renin activity in patients with essential hypertension during exposure to physical load (author's transl)].

  Ondrejicka M, Balazovjech I, Kratochvílová H. Ondrejicka M, et al. Bratisl Lek Listy. 1982 Mar;77(3):270-80. Bratisl Lek Listy. 1982. PMID: 7042035 Slovak. No abstract available.
• [Proceedings: Serum dopamine beta hydroxylase activity. 2. Evaluation of thyroid diseases].

  Nishizawa Y, Hamada N, Okuda K, Fujii A, Morii H. Nishizawa Y, et al. Nihon Naibunpi Gakkai Zasshi. 1974 Feb 20;50(2):642. Nihon Naibunpi Gakkai Zasshi. 1974. PMID: 4476635 Japanese. No abstract available.
• Serum dopamine-beta-hydroxylase as an indicator of sympathetic activity and primary hypertension.

  Schanberg SM, Kirshner N. Schanberg SM, et al. Biochem Pharmacol. 1976 Mar 15;25(6):617-21. doi: 10.1016/0006-2952(76)90233-1. Biochem Pharmacol. 1976. PMID: 179553 Review. No abstract available.